Literature DB >> 22037028

Buy buy bispecific antibodies.

David Holmes.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22037028     DOI： 10.1038/nrd3581

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  24 in total

1.  Synthesis of bispecific antibodies using genetically encoded unnatural amino acids.

Authors:  Chan Hyuk Kim; Jun Y Axup; Anna Dubrovska; Stephanie A Kazane; Benjamin A Hutchins; Erik D Wold; Vaughn V Smider; Peter G Schultz
Journal:  J Am Chem Soc       Date:  2012-06-06       Impact factor: 15.419

Review 2.  Recent advances in tumor associated carbohydrate antigen based chimeric antigen receptor T cells and bispecific antibodies for anti-cancer immunotherapy.

Authors:  Zahra Rashidijahanabad; Xuefei Huang
Journal:  Semin Immunol       Date:  2020-01-22       Impact factor: 11.130

Review 3.  Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies.

Authors:  Christian Klein; Claudio Sustmann; Markus Thomas; Kay Stubenrauch; Rebecca Croasdale; Jürgen Schanzer; Ulrich Brinkmann; Hubert Kettenberger; Jörg T Regula; Wolfgang Schaefer
Journal:  MAbs       Date:  2012-08-27       Impact factor: 5.857

4.  Non-viral adeno-associated virus-based platform for stable expression of antibody combination therapeutics.

Authors:  Gwendolyn M Wilmes; Kimberly L Carey; Stuart W Hicks; Hugh H Russell; Jesse A Stevenson; Paulina Kocjan; Stephen R Lutz; Rachel S Quesenberry; Sergey V Shulga-Morskoy; Megan E Lewis; Ethan Clark; Violetta Medik; Anthony B Cooper; Elizabeth E Reczek
Journal:  MAbs       Date:  2014-04-23       Impact factor: 5.857

5.  Simulations of site-specific target-mediated pharmacokinetic models for guiding the development of bispecific antibodies.

Authors:  Vaishali L Chudasama; Anup Zutshi; Pratap Singh; Anson K Abraham; Donald E Mager; John M Harrold
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-01-06       Impact factor: 2.745

6.  Chemically programmed bispecific antibodies that recruit and activate T cells.

Authors:  Huiting Cui; Joshua D Thomas; Terrence R Burke; Christoph Rader
Journal:  J Biol Chem       Date:  2012-07-03       Impact factor: 5.157

7.  Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) × c-MET Antibodies and Antibody-Drug Conjugates.

Authors:  Carolin Sellmann; Achim Doerner; Christine Knuehl; Nicolas Rasche; Vanita Sood; Simon Krah; Laura Rhiel; Annika Messemer; John Wesolowski; Mark Schuette; Stefan Becker; Lars Toleikis; Harald Kolmar; Bjoern Hock
Journal:  J Biol Chem       Date:  2016-09-30       Impact factor: 5.157

8.  DNA "nano-claw": logic-based autonomous cancer targeting and therapy.

Authors:  Mingxu You; Lu Peng; Na Shao; Liqin Zhang; Liping Qiu; Cheng Cui; Weihong Tan
Journal:  J Am Chem Soc       Date:  2014-01-13       Impact factor: 15.419

9.  Self-assembled antibody multimers through peptide nucleic acid conjugation.

Authors:  Stephanie A Kazane; Jun Y Axup; Chan Hyuk Kim; Mihai Ciobanu; Erik D Wold; Sofia Barluenga; Benjamin A Hutchins; Peter G Schultz; Nicolas Winssinger; Vaughn V Smider
Journal:  J Am Chem Soc       Date:  2012-12-21       Impact factor: 15.419

10.  Bifunctional lipocalin ameliorates murine immune complex-induced acute lung injury.

Authors:  Pietro Roversi; Bernhard Ryffel; Dieudonnée Togbe; Isabelle Maillet; Mauro Teixeira; Nurfilza Ahmat; Guido C Paesen; Olga Lissina; Wilhelm Boland; Kerstin Ploss; Joseph J E Caesar; Susanne Leonhartsberger; Susan M Lea; Miles A Nunn
Journal:  J Biol Chem       Date:  2013-04-26       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.